A new handheld device could identify skin cancers without the need for a painful biopsy, according to a new study.
Scientists say that the new tool could cut unnecessary biopsies in half and make it easier for doctors to diagnose cancer.
In recent years, the number of biopsies performed on American Medicare users has grown around four times faster than the number of cancers detected.
Around 30 benign bits of skin damage are now biopsied for every one cancer that is found using the painful procedure.
The process, during which doctors carve away small bits of tissue for lab testing, leaves patients with painful wounds that sometimes take weeks to heal.
The new device, being developed at Stevens Institute of Technology, uses millimeter-wave imaging, which is also used in airport security scanners, to scan a patient’s skin.
Healthy tissue reflects the waves differently to cancerous tissue, allowing cancers to be spotted.
To make the technology fit for clinical practice, the researchers used algorithms to fuse signals captured by different antennas into a single ultrahigh-bandwidth image.
This allows even the tiniest mole or blemish to be spotted in the high-resolution images.
The rays harmlessly penetrate around 2mm into human skin and the technology gives doctors a 3D map of scanned lesions.
In real world clinical visits to 71 people, a tabletop version of the technology could accurately distinguish between benign and malign skin lesions in just a few seconds.
The device could identify cancerous tissue with 97 percent sensitivity and 98 percent specificity, a similar rate to most hospital-grade diagnostic tools.
The tech delivers results in seconds, meaning it could one day be used instead of a magnifying dermatoscope to give accurate results at check-ups almost instantly- in turn allowing doctors to treat more patients.
Now, the researchers want to pack the team’s diagnostic kit onto an integrated circuit. This step could soon allow functional handheld millimeter-wave diagnostic devices to be produced for as little as £80 ($100) a piece — a fraction of the cost of existing hospital-grade diagnostic equipment.
The team hope to bring their product to market within the next two years.
Dr. Negar Tavassolian, who helped develop the tool said: “We aren’t trying to get rid of biopsies, but we do want to give doctors additional tools and help them to make better decisions.
“There are other advanced imaging technologies that can detect skin cancers, but they’re big, expensive machines that aren’t available in the clinic.
“We’re creating a low-cost device that’s as small and as easy to use as a cellphone, so we can bring advanced diagnostics within reach for everyone.
“The path forward is clear, and we know what we need to do.
“After this proof of concept, we need to miniaturize our technology, bring the price down, and bring it to the market.”
Stories and infographics by ‘Talker Research’ are available to download & ready to use. Stories and videos by ‘Talker News’ are managed by SWNS. To license content for editorial or commercial use and to see the full scope of SWNS content, please email [email protected] or submit an inquiry via our contact form.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.